Home/Filings/4/0001209191-17-033586
4//SEC Filing

ENDRA Life Sciences Inc. 4

Accession 0001209191-17-033586

$NDRACIK 0001681682operating

Filed

May 17, 8:00 PM ET

Accepted

May 18, 4:25 PM ET

Size

5.2 KB

Accession

0001209191-17-033586

Insider Transaction Report

Form 4
Period: 2017-05-12
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options

    2017-05-12+12,00012,000 total
    Exercise: $5.00From: 2017-05-12Exp: 2022-05-12Common Stock (12,000 underlying)

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001681682

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:25 PM ET
Size
5.2 KB